Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Stablecoin Development Corporation (SDEV : AMEX)

• Company Description    NovaBay Pharmaceuticals, Inc. is a biopharmaceutical company focused on developing innovative product candidates targeting the treatment or prevention of a wide range of infections in hospital and non-hospital environments. NovaBay has discovered and is developing a class of antimicrobial compounds, which it has named Aganocide compounds, which are based upon small molecules that are generated by white blood cells that defend the body against invading pathogens. NovaBay believes that Aganocide compounds could form a platform on which to create a variety of products to address differing needs in the treatment and prevention of bacterial and viral infections, including Methicillin-Resistant Staphylococcus aureus. Number of Employees: 4

• Price / Volume Information    Yesterday's Closing Price: $1.41 Daily Weekly Monthly 20 Day Moving Average: 98,200 shares Shares Outstanding: 27.12 (millions) Market Capitalization: $38.23 (millions) Beta: 0.16 52 Week High: $99.75 52 Week Low: $1.11 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week 9.30% 3.96% 12 Week -7.84% -14.81% Year To Date -95.00% -95.18%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 2000 POWELL STREET SUITE 1150 - EMERYVILLE,CA 94608 USA ph: 510-899-8800 fax: 510-474-1577 jcain@allianceadvisors.com https://stabledev.com

• General Corporate Information    Officers Michael Kazley - Chairman & Chief Executive Officer Tommy Law - Chief Financial Officer Paul E. Freiman - Director Swan Sit - Director Yenyou (Jeff) Zheng - Director Peer Information Stablecoin Development Corporation (EIIN) Stablecoin Development Corporation (AFMI) Stablecoin Development Corporation (DRL) Stablecoin Development Corporation (GRFPY) Stablecoin Development Corporation (IGOT) Stablecoin Development Corporation (ATLC) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: FIN-MISC SVCS Sector: Finance CUSIP: 66987P508 SIC: 2834 Fiscal Year Fiscal Year End: December Last Reported Quarter: 03/01/26 Next Expected EPS Date: 08/13/26 Share - Related Items Shares Outstanding: 27.12 Most Recent Split Date: 2.00 (0.20:1) Beta: 0.16 Market Capitalization: $38.23 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio: Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 08/13/26

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 0.28 Price/Cash Flow: - Price / Sales: - EPS Growth vs. Year Ago Period: 103.28% vs. Previous Quarter: -% Sales Growth vs. Year Ago Period: -% vs. Previous Quarter: -% ROE 03/31/26 - -42.59 12/31/25 - - 09/30/25 - -445.74 ROA 03/31/26 - -25.06 12/31/25 - -453.46 09/30/25 - -142.64 Current Ratio 03/31/26 - 5.33 12/31/25 - 7.60 09/30/25 - 2.00 Quick Ratio 03/31/26 - - 12/31/25 - 7.60 09/30/25 - 2.00 Operating Margin 03/31/26 - - 12/31/25 - - 09/30/25 - - Net Margin 03/31/26 - - 12/31/25 - - 09/30/25 - - Pre-Tax Margin 03/31/26 - 21,354.65 12/31/25 - - 09/30/25 - -1,621.69 Book Value 03/31/26 - 5.12 12/31/25 - -0.92 09/30/25 - -2.23 Inventory Turnover 03/31/26 - 0.00 12/31/25 - 0.00 09/30/25 - 4.10 Debt-to-Equity 03/31/26 - 0.00 12/31/25 - - 09/30/25 - - Debt-to-Capital 03/31/26 - 0.00 12/31/25 - - 09/30/25 - 0.00

Powered by Zacks Investment Research ©